Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects

Robert P. Takes, Alessandra Rinaldo, Carl E. Silver, Missak Haigentz, Julia A. Woolgar, Asterios Triantafyllou, Vanni Mondin, Daniela Paccagnella, Remco De Bree, Ashok R. Shaha, Dana M. Hartl, Alfio Ferlito

Research output: Contribution to journalReview article

62 Citations (Scopus)

Abstract

The incidence of distant metastasis in head and neck squamous cell carcinoma (HNSCC) is relatively low but remains a major determinant of prognosis and therefore an important factor in clinical decision making. The most frequently involved sites for distant metastasis are the lung (approximately 70% of cases), followed by bone and liver. There are often conflicting reports on which parameters are risk factors for distant metastasis, but the most important predictive factors appear to be the site of the primary tumor (hypopharynx in particular), advanced T- and N-classification, histological grade and the ability to achieve locoregional disease control. Metastasis results from a selection of tumor cells that have acquired the properties to withstand multiple and often unfavorable circumstances and settle in distant organs. Most of these processes involve interaction between tumor cells, their microenvironment and host factors. Increasing knowledge of the biology of distant metastasis may result in the development of diagnostic and therapeutic strategies targeted to this usually terminal stage for patients with HNSCC.

Original languageEnglish (US)
Pages (from-to)775-779
Number of pages5
JournalOral Oncology
Volume48
Issue number9
DOIs
StatePublished - Sep 1 2012
Externally publishedYes

Fingerprint

Neoplasm Metastasis
Cellular Microenvironment
Hypopharynx
Neoplasms
Carcinoma, squamous cell of head and neck
Bone and Bones
Lung
Liver
Incidence
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Oral Surgery
  • Cancer Research

Cite this

Takes, R. P., Rinaldo, A., Silver, C. E., Haigentz, M., Woolgar, J. A., Triantafyllou, A., ... Ferlito, A. (2012). Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. Oral Oncology, 48(9), 775-779. https://doi.org/10.1016/j.oraloncology.2012.03.013
Takes, Robert P. ; Rinaldo, Alessandra ; Silver, Carl E. ; Haigentz, Missak ; Woolgar, Julia A. ; Triantafyllou, Asterios ; Mondin, Vanni ; Paccagnella, Daniela ; De Bree, Remco ; Shaha, Ashok R. ; Hartl, Dana M. ; Ferlito, Alfio. / Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. In: Oral Oncology. 2012 ; Vol. 48, No. 9. pp. 775-779.
@article{8dd6c13f7c2a4128a1beb294cc9c8d32,
title = "Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects",
abstract = "The incidence of distant metastasis in head and neck squamous cell carcinoma (HNSCC) is relatively low but remains a major determinant of prognosis and therefore an important factor in clinical decision making. The most frequently involved sites for distant metastasis are the lung (approximately 70{\%} of cases), followed by bone and liver. There are often conflicting reports on which parameters are risk factors for distant metastasis, but the most important predictive factors appear to be the site of the primary tumor (hypopharynx in particular), advanced T- and N-classification, histological grade and the ability to achieve locoregional disease control. Metastasis results from a selection of tumor cells that have acquired the properties to withstand multiple and often unfavorable circumstances and settle in distant organs. Most of these processes involve interaction between tumor cells, their microenvironment and host factors. Increasing knowledge of the biology of distant metastasis may result in the development of diagnostic and therapeutic strategies targeted to this usually terminal stage for patients with HNSCC.",
author = "Takes, {Robert P.} and Alessandra Rinaldo and Silver, {Carl E.} and Missak Haigentz and Woolgar, {Julia A.} and Asterios Triantafyllou and Vanni Mondin and Daniela Paccagnella and {De Bree}, Remco and Shaha, {Ashok R.} and Hartl, {Dana M.} and Alfio Ferlito",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.oraloncology.2012.03.013",
language = "English (US)",
volume = "48",
pages = "775--779",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "9",

}

Takes, RP, Rinaldo, A, Silver, CE, Haigentz, M, Woolgar, JA, Triantafyllou, A, Mondin, V, Paccagnella, D, De Bree, R, Shaha, AR, Hartl, DM & Ferlito, A 2012, 'Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects', Oral Oncology, vol. 48, no. 9, pp. 775-779. https://doi.org/10.1016/j.oraloncology.2012.03.013

Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. / Takes, Robert P.; Rinaldo, Alessandra; Silver, Carl E.; Haigentz, Missak; Woolgar, Julia A.; Triantafyllou, Asterios; Mondin, Vanni; Paccagnella, Daniela; De Bree, Remco; Shaha, Ashok R.; Hartl, Dana M.; Ferlito, Alfio.

In: Oral Oncology, Vol. 48, No. 9, 01.09.2012, p. 775-779.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects

AU - Takes, Robert P.

AU - Rinaldo, Alessandra

AU - Silver, Carl E.

AU - Haigentz, Missak

AU - Woolgar, Julia A.

AU - Triantafyllou, Asterios

AU - Mondin, Vanni

AU - Paccagnella, Daniela

AU - De Bree, Remco

AU - Shaha, Ashok R.

AU - Hartl, Dana M.

AU - Ferlito, Alfio

PY - 2012/9/1

Y1 - 2012/9/1

N2 - The incidence of distant metastasis in head and neck squamous cell carcinoma (HNSCC) is relatively low but remains a major determinant of prognosis and therefore an important factor in clinical decision making. The most frequently involved sites for distant metastasis are the lung (approximately 70% of cases), followed by bone and liver. There are often conflicting reports on which parameters are risk factors for distant metastasis, but the most important predictive factors appear to be the site of the primary tumor (hypopharynx in particular), advanced T- and N-classification, histological grade and the ability to achieve locoregional disease control. Metastasis results from a selection of tumor cells that have acquired the properties to withstand multiple and often unfavorable circumstances and settle in distant organs. Most of these processes involve interaction between tumor cells, their microenvironment and host factors. Increasing knowledge of the biology of distant metastasis may result in the development of diagnostic and therapeutic strategies targeted to this usually terminal stage for patients with HNSCC.

AB - The incidence of distant metastasis in head and neck squamous cell carcinoma (HNSCC) is relatively low but remains a major determinant of prognosis and therefore an important factor in clinical decision making. The most frequently involved sites for distant metastasis are the lung (approximately 70% of cases), followed by bone and liver. There are often conflicting reports on which parameters are risk factors for distant metastasis, but the most important predictive factors appear to be the site of the primary tumor (hypopharynx in particular), advanced T- and N-classification, histological grade and the ability to achieve locoregional disease control. Metastasis results from a selection of tumor cells that have acquired the properties to withstand multiple and often unfavorable circumstances and settle in distant organs. Most of these processes involve interaction between tumor cells, their microenvironment and host factors. Increasing knowledge of the biology of distant metastasis may result in the development of diagnostic and therapeutic strategies targeted to this usually terminal stage for patients with HNSCC.

UR - http://www.scopus.com/inward/record.url?scp=84865177563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865177563&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2012.03.013

DO - 10.1016/j.oraloncology.2012.03.013

M3 - Review article

VL - 48

SP - 775

EP - 779

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 9

ER -